VITAL THERAPIES INC Business Finance Contracts & Agreements
22 Contracts & Agreements
- Exchange Agreements (1 contract)
- Guarantee Agreements (1)
- Investment Agreements (2)
- Investor Rights Agreements (3)
- Purchase Agreements (7)
- Stock Agreements (1)
- Underwriting Agreements (6)
- Warrant Agreements (1)
- Securities Purchase Agreement, dated October 10, 2022, by and among the Company and the Purchasers (Filed With SEC on October 11, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on October 11, 2022)
- Underwriting Agreement, dated July 15, 2021, by and between Immunic, Inc. and Piper Sandler & Co (Filed With SEC on July 19, 2021)
- Form of Guarantee Agreement between Immunic, Inc., Immunic AG and European Investment Bank (Filed With SEC on October 20, 2020)
- Underwriting Agreement, dated August 4, 2020, by and between Immunic, Inc. and SVB Leerink LLC (Filed With SEC on August 10, 2020)
- Form of Securities Purchase Agreement, dated June 10, 2020, between the Company and the investors party thereto (Filed With SEC on June 12, 2020)
- Form of Securities Purchase Agreement, dated April 23, 2020, between the Company and the investors party thereto (Filed With SEC on April 27, 2020)
- Asset Purchase Agreement, dated May 13, 2016, between Immunic AG and 4SC AG (Filed With SEC on July 17, 2019)
- Second Amendment to Asset Purchase Agreement between RH Cell Therapeutics Corp. and Vital Therapies, Inc. dated as of April 4, 2019 (Filed With SEC on April 10, 2019)
- First Amendment to Asset Purchase Agreement between RH Cell Therapeutics Corp. and Vital Therapies, Inc. dated as of March 27, 2019 (Filed With SEC on April 10, 2019)
- Asset Purchase Agreement by and between RH Cell Therapeutics Corp and Vital Therapies, Inc., dated March 13, 2019 (Filed With SEC on March 19, 2019)
- Exchange Agreement, dated as of January 6, 2019 by and among Vital Therapies, Inc., Immunic AG, and the shareholders of Immunic AG (Filed With SEC on January 7, 2019)
- Investment and Subscription Agreement, dated as of January 6, 2019, among Immunic AG and its Shareholders (Filed With SEC on January 7, 2019)
- Investment Banking Agreement between Ladenburg Thalmann & Co. Inc. and Vital Therapies, Inc., dated October 11, 2018 (Filed With SEC on October 12, 2018)
- 5,454,546 Shares Vital Therapies, Inc. Common Stock UNDERWRITING AGREEMENT October 22, 2015 (Filed With SEC on October 23, 2015)
- [] Shares Vital Therapies, Inc. Common Stock UNDERWRITING AGREEMENT [], 2014 (Filed With SEC on September 30, 2014)
- [] Shares Vital Therapies, Inc. Common Stock UNDERWRITING AGREEMENT [], 2014 (Filed With SEC on April 7, 2014)
- [] Shares Vital Therapies, Inc. Common Stock UNDERWRITING AGREEMENT [], 2013 (Filed With SEC on November 6, 2013)
- VITAL THERAPIES, INC. 2012 STOCK OPTION PLAN (amended April 26, 2012) (amended September 25, 2012) (amended July 2, 2013) (amended September 9, 2013) (Filed With SEC on October 11, 2013)
- AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on October 11, 2013)
- INVESTORS RIGHTS AGREEMENT (Filed With SEC on October 11, 2013)
- VITAL THERAPIES, INC. FOURTH AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT August 28, 2013 TABLE OF CONTENTS (Filed With SEC on October 11, 2013)
